Table 5.
Gliclazide dose after titration | |||||||||
---|---|---|---|---|---|---|---|---|---|
0 | 30 | 40 | 60 | 80 | 90 | 120 | 160 | 240 | 320 |
-10(-13, -8)#m=57 | -12(-14, -10)#m=89 | -12(-14, -11)#m=174 | |||||||
8(4, 10)#m=44 | -2(-4, 0)#m=73 | ||||||||
13(10, 15)#m=108 | -6(-7, -3)#m=109 | ||||||||
4(2, 6)#m=49 | -3(-7, 1)#m=38 | -1(-6, 3)#m=33 | |||||||
11(9, 13)#m=91 | 3(2, 4)#m=171 | -3(-4, -2)#m=233 | |||||||
-3(-6, -1)#m=34 | |||||||||
3(2, 4)#m=172 | -1(-4, 1)#m=59 | -3(-6, -1)#m=113 | -4(-7, -2)#m=112 | ||||||
1(-2, 3)#m=50 | -2(-4, 1)#m=77 | ||||||||
2(1, 4)#m=119 | 3(-2, 8)#m=31 |
Change in HbA1c values after gliclazide initiation, titration, or discontinuation. The values above the diagonal represent the instances where the medication has been initiated or up-titrated, while the values below the diagonal represent instances where the medication has been down-titrated or discontinued. The values refer to the mean difference in HbA1c (MD) and 95% confidence intervals. MD below 0 indicate a lowering in HbA1c while those above 0 indicate an increase in HbA1c. #m refers to the number of HbA1c pairs for that dose titration